Dimerization of the erythropoietin (EPO) receptor (EPOR), in the presence of either natural (EPO) or synthetic (EPO-mimetic peptides, EMPs) ligands is the principal extracellular event that leads ...

European Patent Office (EPO): Neeka and Leila Mashouf win the Nature Guardians prize at the Young Inventors Prize 2025 for turning CO₂ into essential materials. PR Newswire.

Erythropoietin, or Epo for short, ... The transcriptional and regulatory identity of erythropoietin producing cells, Nature Medicine (2023) DOI: 10.1038/s41591-023-02314-7.

India has won a 10-year-long battle at the European Patent Office (EPO) against a patent granted on an anti-fungal product, derived from neem. EPO initially granted the patent to the US Department of ...

Erythropoietin, or EPO, boosts production of red blood cells and is used to treat anemia, which is often caused by cancer, chemotherapy, or kidney failure.

European Patent Office (EPO): Neeka and Leila Mashouf win the Nature Guardians prize at the Young Inventors Prize 2025 for turning CO₂ into essential materials. News provided by.